Navigation Links
Winning the battle against leukaemia: Positive early results in clinical trial for DNA vaccine
Date:12/7/2012

Early results of a trial to treat leukaemia with a WT1 DNA vaccine, has shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to date.

Furthermore, T cell immune responses, including those of the "killer T cells," were detected. Antibody and T cell responses are strong signals of the DNA vaccine's potential to treat the disease.

Presented at the DNA Vaccines 2012 conference in California by Christian Ottensmeier, the trial's principal investigator and Professor of Experimental Cancer Research at the University of Southampton, these interim results, from eight patients, are part of a phase II trial that will enroll 31 patients in its chronic myelogenous leukaemia (CML) arm.

To date, 14 CML patients have been enrolled while another 13 unvaccinated CML patients have been enrolled to serve as a control group. The vaccine has been shown to be safe overall and well-tolerated in the trial subjects. A detailed analysis of T cell immune responses as well as the impact of the vaccination on the molecular marker, BCR-ABL, which is a specific chromosomal abnormality that is associated with CML disease, will be performed during the trial.

As a result of the favourable safety and immunogenicity profiles observed in the CML vaccinated group, the trial is now open to enroll the acute myeloid leukaemia (AML) clinical trial arm, with a total target of 37 subjects in each of the vaccinated and control groups.

Professor Ottensmeier comments: "These preliminary data show strong vaccine-induced immune responses in vaccinated subjects in the CML arm. We are looking forward to enrolling and testing the vaccine's impact in AML patients, who currently have limited treatment options and a low rate of progression free survival."

This open-label, multi-center phase II clinical trial is evaluating a DNA vaccine-based immune therapy to treat these two types of leukaemia. The DNA vaccine, developed by the
'/>"/>

Contact: Becky Attwood
r.attwood@soton.ac.uk
44-023-805-95457
University of Southampton
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Version 2.0 of Award-Winning Proloquo2Go App for iPhone, iPad & iPod touch Speeds Up Communication, Adds New Voices and Customization Options
2. Elsevier congratulates its British Medical Association award winning medical authors and editors
3. Best Christmas Gift for 2012: Instant Stress Relief on CD! Relaxintuit.com’s Award-Winning Meditation CD Soothes Anxiety, Depression, Pain & Supports Deep, Healthy Sleep
4. One-third of adult Americans with arthritis battle anxiety or depression
5. Scientists identify new target to battle rheumatoid arthritis
6. Author, Speaker Richard London Battles Parkinson’s with an Active Lifestyle and the Desire to Give Back
7. Disabled Americans Battle for Access to Hotel Pools
8. Nathan Wells Releases Audiobook Detailing Battle with Undiagnosed Medical Condition
9. New Online Resource Acts As Powerful Tool in the Battle against Cancer
10. Scientists identify major source of cells defense against oxidative stress
11. Omega-3 Supplements No Help Against Repeat Heart Trouble: Review
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Como, Italy (PRWEB) March 31, 2015 ... that the design project Bruker EVOQ by Daniel Dion ... A' Design Award in Scientific Instruments, Medical Devices and ... Bruker EVOQ, Daniel Dion, the creative mind behind the ... Bruker EVOQ MS - developed under the direction of ...
(Date:3/31/2015)... 2015 Diane Blackburn-Zambetti is the ... Mesothelioma Applied Research Foundation (Meso Foundation). Blackburn-Zambetti will ... Health” at the BoRit Asbestos Superfund Citizen Advisory ... program will discuss anatomy, six types of asbestos, ... symptoms, treatments, prevention and proper communication with your ...
(Date:3/31/2015)... 2015 According to a recent YouGov/Huffington ... Americans interviewed supported detox and abstinence, while only 19% ... methadone.(1) Although many within the healthcare community advocate for ... suggest that most Americans concur with Novus Medical ... drug use is a better approach than prescribing other ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 PharmMD ... Victor Mattingly to the newly created, senior executive role ... Mattingly’s mandate is the delivery of high quality, efficient, ... building on PharmMD’s current momentum as a market innovator ... Therapy Management. , “We were very strategic in ...
(Date:3/31/2015)... A team of Italian scientists is using nanoparticles ... mesothelioma cancer cells. Surviving Mesothelioma has just posted an ... Click here to read it now. , Curcumin, ... spice turmeric, has limited value as a cancer treatment ... di Napoli Federico II are getting around the problem ...
Breaking Medicine News(10 mins):Health News:Daniel Dion wins Golden in A' Medical Product Design Awards 2Health News:Mesothelioma Foundation to speak at BoRit Asbestos Superfund Citizen Advisory Group Meeting 2Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 2Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 3Health News:Novus Medical Detox Center Highlights Survey Findings: More Americans Support Detox and Rehab Over Methadone as Treatment for Heroin Addiction 4Health News:PharmMD Places Victor Mattingly in C-Suite, Company Focused on Medication Therapy Management and Part D Star Ratings 2Health News:New Research Reveals Novel Delivery Method for Potential Mesothelioma Treatment, According to Surviving Mesothelioma 2
... and Care Reminder System Improves Patient Care, ... (http://www.wellcentive.com ) today announced the launch of ... system, which utilizes Voice Over,Internet Protocol (VoIP) ... effectively reminds patients about upcoming,appointments or overdue ...
... How do you stay younger ... weekly yoga class, playing with your ... report from BP at:, http://media.medialink.com/WebNR.aspx?story=35426 ... audio, text, graphics and,photos for free ...
... Zix Corporation (ZixCorp(R)),(Nasdaq: ZIXI ), the ... today announced Peter Wilensky, the company,s vice president,of ... at the,RBC Capital Markets, Technology, Media and Communications ... at 11:30 a.m. PT., The conference will ...
... help determine if physical fitness increases the body,s,ability ... healthy men and,women, PHOENIX, Aug. 6 ... a research grant from the,National Institutes of Health ... its effects on seniors. Previous studies have discovered,that ...
... Drug Safety Monitoring Service; ... 30,000 More Register Weekly, RESEARCH TRIANGLE PARK, ... the safety of their medications automatically,monitored by iGuard.org, a secure, patient-driven ... Founded by drug safety researchers in October 2007, iGuard is a ...
... Although maternal suicide after giving birth is a ... on the family and the infant. In a study ... American Journal of Obstetrics & Gynecology, researchers compared ... of psychiatric disorders or substance abuse was a strong ...
Cached Medicine News:Health News:WellCentive Launches the WellCentive Outreach System 2Health News:WellCentive Launches the WellCentive Outreach System 3Health News:KLRI Receives Grant From NIH to Study Stress Resilience in Older Adults 2Health News:iGuard.org Reaches 500,000-Member Milestone 12 Months Early 2Health News:Post-partum suicide attempt risks studied 2
(Date:3/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/sx7b45/european ... "European Laboratory Information System (LIS) Market by Product ... Laboratory Information System, Anatomic Pathology Laboratory Information System) ... offering. The European laboratory information systems ... of 7.6% from 2014 to 2019. ...
(Date:3/31/2015)... , March 31, 2015 ... today announced a strategic partnership with Medidata ... for clinical research in life sciences. Offering therapeutic ... CRO has deployed Medidata,s electronic data capture (EDC), ... Biorasi,s Phase I through IV global clinical trial ...
(Date:3/31/2015)... Research and Markets ( http://www.researchandmarkets.com/research/dlt2vp/north_american ... "North American Laboratory Information System (LIS) Market by ... Pathology Laboratory Information System, Anatomic Pathology Laboratory Information ... their offering. The North American Laboratory ... a CAGR of 7.8% from 2014 to 2019. ...
Breaking Medicine Technology:European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 2European Laboratory Information System Market Report 2015: Germany holds a larger share of the laboratory information systems market 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 2Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 3Biorasi Selects Medidata's Cloud-Based Platform for Optimal Trial Operations 4North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 2North American Laboratory Information System (Clinical Pathology Laboratory Information System, Anatomic Pathology Laboratory Information) Market 2015-2019 3
... OXFORD, England, September 26, 2011 EJC App Now ... provider of scientific, technical and medical information products and services, today ... Journal of Cancer ( EJC ). Starting with the September ... will be available through the EJC App on the App Store. ...
... InterMune, Inc. (NASDAQ: ITMN ) today reported ... Society (ERS) Annual Congress supporting the longer-term safety and ... idiopathic pulmonary fibrosis (IPF), a devastating lung disease.  Approximately ... year, with an estimated median survival of only two ...
Cached Medicine Technology:Elsevier Launches European Journal of Cancer iPad Edition 2Elsevier Launches European Journal of Cancer iPad Edition 3New Data Demonstrate Longer-Term Safety Profile of Esbriet® 2New Data Demonstrate Longer-Term Safety Profile of Esbriet® 3New Data Demonstrate Longer-Term Safety Profile of Esbriet® 4New Data Demonstrate Longer-Term Safety Profile of Esbriet® 5New Data Demonstrate Longer-Term Safety Profile of Esbriet® 6
... Preserve your data for future generations. Most gels ... solid backing plate of our gel dryer, covering ... frame over them to hold the cellophane flat. ... frame with an open area somewhat larger than ...
... Most gels can be dried by positioning them ... dryer, covering them with wet semi-permeable cellophane and ... cellophane flat. Tut's Tombs also produce great fluorographs. ... larger than the gel to be dried. Note ...
... Preserve your data for future generations. Most gels ... solid backing plate of our gel dryer, covering ... frame over them to hold the cellophane flat. ... frame with an open area somewhat larger than ...
... Easy Breeze Air Gel Dryer : Dry up ... 24 gels 8 10 cm without a ... rapid drying, or no heat for controlled drying ... transparent, dried gels. Add and remove gels at ...
Medicine Products: